REVELATION BIOSCIENCES, INC. - COM NEW (REVB)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM NEW
Number of holders
7
Total 13F shares, excl. options
83,661
Shares change
+79,122
Total reported value, excl. options
$63,179
Value change
+$58,145
Number of buys
5
Number of sells
-3
Price
$0.75

Significant Holders of REVELATION BIOSCIENCES, INC. - COM NEW (REVB) as of Q2 2025

9 filings reported holding REVB - REVELATION BIOSCIENCES, INC. - COM NEW as of Q2 2025.
REVELATION BIOSCIENCES, INC. - COM NEW (REVB) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,661 shares .
Largest 9 shareholders include SABBY MANAGEMENT, LLC (65,789 shares), StoneX Group Inc. (10,211 shares), Tower Research Capital LLC (TRC) (3,478 shares), Royal Bank of Canada (3,422 shares), UBS Group AG (751 shares), BANK OF AMERICA CORP /DE/ (9 shares), DANSKE BANK A/S (1 shares), SBI Securities Co., Ltd. (0 shares), and IFP Advisors, Inc (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.